NCT00406991View on ClinicalTrials.gov

Retinal Blood Flow and Microthrombi in Type 1 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

March 31, 2006

Conditions
DiabetesDiabetic Retinopathy
Interventions
DRUG

aspirin

DRUG

clopidogrel

Trial Locations (1)

02114

Schepens Eye Research Institute, Boston

All Listed Sponsors
lead

Schepens Eye Research Institute

OTHER

NCT00406991 - Retinal Blood Flow and Microthrombi in Type 1 Diabetes | Biotech Hunter | Biotech Hunter